Description

T3 50 mcg by Swiss Healthcare contains Liothyronine Sodium, the synthetic form of triiodothyronine (T3) — the active thyroid hormone responsible for regulating metabolic rate, temperature control, and cellular energy production. Historically used in clinical settings to treat hypothyroidism, fatigue, and metabolic disorders, T3 is now widely utilized in research studying fat metabolism, thyroid function, and hormonal optimization.

Due to its high bioactivity and short half-life, Liothyronine is fast-acting and particularly relevant in studies assessing thermogenesis, lipolysis, and mitochondrial output. It is significantly more potent than T4 (Levothyroxine), making precise dosing essential in experimental applications.

Swiss Healthcare manufactures T3 50 mcg under pharmaceutical-grade standards, with each bottle containing 60 oral tablets to ensure consistent, accurate dosing for laboratory-based studies.

Product Details

• Active Ingredient: Liothyronine Sodium (T3)

• Concentration per Tablet: 50 mcg

• Form: Oral tablets

• Package Size: 60 tablets per bottle

Pharmacokinetics

T3 has a half-life of approximately 1 day and reaches peak plasma levels within 2–4 hours after ingestion. It is rapidly absorbed and exerts direct influence on metabolic rate, oxygen consumption, and thermoregulation. Its short duration of action requires consistent, timed administration in research protocols.

Usage Recommendations

• Typical Research Dosage (historical reference): 25–75 mcg per day

• Current Use: For research and laboratory purposes only

• Administration: Oral

Disclaimer

This product is intended strictly for research and laboratory use only. It is not approved for human use or therapeutic consumption. Not suitable for individuals under 18, pregnant or breastfeeding women, or those with cardiovascular, thyroid, or metabolic conditions. Always follow all regulatory guidelines and laboratory safety protocols.